Saphire, Erica Ollmann
- La Jolla Institute for Immunology (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #419
- Rising Star
- Sustained Excellence
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$7.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#419
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Saphire, Erica Ollmann as a PI. Multi-PI records show the full award amount for context.
- 5U19AI142790-05U19Contact PIConsortium for Immunotherapeutics against Emerging Viral Threats$7Maward amount
- 1R21AI178427-01R21Contact PIStructure of the SARS-CoV-2 Nucleocapsid: building block to viral capsid$285.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Saphire, Erica Ollmann as a PI.
FY2023 award administered by La Jolla Institute for Immunology (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardLa Jolla Institute for Immunology
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #4479
- 2006Entered Top 25% NationallyRanked #4479
- 2007$2M Cumulative Funding
- 2009$5M Cumulative Funding
- 2010Entered Top 10% NationallyRanked #1851
- 2012$10M Cumulative Funding
- 2014Entered Top 5% NationallyRanked #381
- 2015$25M Cumulative Funding
- 2019$50M Cumulative Funding
- 2020Entered Top 1% NationallyRanked #98